AGF Investments LLC’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-32,877
| Closed | -$796K | – | 384 |
|
|
2022
Q1 | $796K | Sell |
32,877
-8,417
| -20% | -$204K | 0.07% | 202 |
|
|
2021
Q4 | $964K | Buy |
41,294
+4,110
| +11% | +$95.9K | 0.08% | 52 |
|
|
2021
Q3 | $618K | Buy |
37,184
+8,758
| +31% | +$146K | 0.06% | 121 |
|
|
2021
Q2 | $693K | Buy |
+28,426
| New | +$693K | 0.07% | 73 |
|
|
2020
Q3 | – | Sell |
-464
| Closed | -$22K | – | 547 |
|
|
2020
Q2 | $22K | Buy |
464
+277
| +148% | +$13.1K | ﹤0.01% | 461 |
|
|
2020
Q1 | $8K | Buy |
187
+54
| +41% | +$2.31K | ﹤0.01% | 488 |
|
|
2019
Q4 | $6K | Sell |
133
-268
| -67% | -$12.1K | ﹤0.01% | 519 |
|
|
2019
Q3 | $14K | Buy |
401
+99
| +33% | +$3.46K | ﹤0.01% | 474 |
|
|
2019
Q2 | $8K | Buy |
+302
| New | +$8K | ﹤0.01% | 537 |
|
|
2018
Q1 | – | Sell |
-300
| Closed | -$9K | – | 650 |
|
|
2017
Q4 | $9K | Buy |
300
+46
| +18% | +$1.38K | ﹤0.01% | 554 |
|
|
2017
Q3 | $10K | Sell |
254
-108
| -30% | -$4.25K | ﹤0.01% | 490 |
|
|
2017
Q2 | $10K | Buy |
362
+82
| +29% | +$2.27K | ﹤0.01% | 460 |
|
|
2017
Q1 | $10K | Sell |
280
-64
| -19% | -$2.29K | ﹤0.01% | 466 |
|
|
2016
Q4 | $10K | Buy |
+344
| New | +$10K | ﹤0.01% | 560 |
|